Multiple Ascending Dose Study of NH102 in Healthy Subjects
Status:
COMPLETED
Trial end date:
2023-04-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of NH102 when administered as multiple oral dose at escalating dose levels in healthy participants.